News
Lymphoma and leukemia cancers are distinct, but it's possible to have both at the same time. If you have a particular type of leukemia, it's possible for it to develop into lymphoma.
Manoj Jewellers IPO Subscription Status At the end of the third day of the bidding process, Manoj Jewellers IPO received 32,44,000 shares as against 28,48,000 shares on offer, garnering 1.14 times ...
IPO GMP News Live Updates: What is the latest GMP for Srigee DLM SME IPO As of the latest update on May 6, 2025, at 01:56 PM, the GMP (Grey Market Premium) for Srigee DLM SME IPO stands at Rs 30 ...
Kenrik Industries IPO GMP or grey market premium was ₹ 0, which meant shares were trading at their issue price of ₹ 25 with no premium or discount in the grey market according to investorgain.com ...
Biotech Biomea cuts 35% of staff, drops leukemia asset in pivot to metabolic disease By Darren Incorvaia May 5, 2025 6:59pm metabolic drugs biotech layoffs pipeline Diabetes ...
Patients with AML who were ≥ 65 years (≥ 60 years if monosomal karyotype) and fit for intensive chemotherapy were allocated to venetoclax dose-escalation cohorts (range, 50-600 mg). Venetoclax was ...
Ather Energy NSE, BSE Share Price Listing, Allotment Status, GMP, Price Band Highlights: Ather Energy's IPO listing today after bidding close on April 30; watch how the electric two-wheeler maker ...
Hosted on MSN2mon
Ather Energy IPO Listing Date: Gains for investors? Latest GMP, BSE and NSE listing price prediction - MSNAther Energy IPO Listing Date: The initial public offering of Ather Energy, with a price band of Rs 304-321 apiece, was the first mainboard public issue of the current financial year 2025-26. It ...
At specific doses, NMN supplements may help improve insulin sensitivity and heart function and reduce tiredness with few side effects. But it’s a good idea to speak with a doctor before trying it.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results